Jeffs Roger
- SEC CIK
- 0001231615
In the past year, 14 open-market sale filings worth $31.9M and no purchases.
Current role at each company
- LQDA Liquidia CorpChief Executive Officeras of Jul 14, 2026
- AXSM Axsome Therapeutics, Inc.Directoras of Jun 11, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $31.9M
- 14 filings
- Net
- −$31.9M
- Bought minus sold
- Companies
- 2
- With open-market trades
Trades
Every Form 4 that lists Jeffs Roger as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
LQDA Liquidia Corp
Chief Executive Officer26 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| May 25, 2022 (view filing) | May 24 | 1 day | Jeffs RogerChief Executive Officer | PPurchase | +28.0K | $3.53 | +$98.8K | +150.6%46.6K after | |
| Sep 7, 2022 (view filing) | Sep 6 | 1 day | Jeffs RogerChief Executive Officer | PPurchase | +43.8K | $5.57 | +$244.1K | +37.8%159.8K after | |
| Dec 18, 2023 (view filing) | Dec 14 | 4 days | Jeffs RogerChief Executive Officer | PPurchase | +139.7K | $7.16 | +$1.00M | +27.9%640.8K after | |
| Mar 19, 2024 (view filing) | Mar 18 | 1 day | Jeffs RogerChief Executive Officer | SSale | −28.6K | $15.82 | −$452.2K | −3.3%835.3K after | 10b5-1 |
| Apr 16, 2024 (view filing) | Apr 12 | 4 days | Jeffs RogerChief Executive Officer | SSale | −8.36K | $14.58 | −$121.9K | −1.0%827.0K after | 10b5-1 |
| Jul 15, 2024 (view filing) | Jul 12 | 3 days | Jeffs RogerChief Executive Officer | SSale | −8.05K | $12.53 | −$100.9K | −1.0%818.9K after | 10b5-1 |
| Oct 15, 2024 (view filing) | Oct 14 | 1 day | Jeffs RogerChief Executive Officer | SSale | −8.05K | $11.11 | −$89.5K | −1.0%812.2K after | 10b5-1 |
| Jan 14, 2025 (view filing) | Jan 14 | Same day | Jeffs RogerChief Executive Officer | SSale | −22.3K | $11.78 | −$263.2K | −2.1%1.02M after | 10b5-1 |
| Apr 16, 2025 (view filing) | Apr 14 | 2 days | Jeffs RogerChief Executive Officer | SSale | −14.1K | $13.57 | −$191.7K | −1.4%1.01M after | 10b5-1 |
| Jun 5, 2025 (view filing) | Jun 4 | 1 day | Jeffs RogerChief Executive Officer | SSale | −30.6K | $16.97 | −$519.5K | −2.8%1.04M after | 10b5-1 |
AXSM Axsome Therapeutics, Inc.
Director6 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Nov 23, 2021 (view filing) | Nov 19 | 4 days | Jeffs RogerDirector | PPurchase | +3.95K | $37.30 | +$147.3K | +3.4%120.8K after | |
| Mar 15, 2024 (view filing) | Mar 14-15 | 1 day | Jeffs RogerDirector | SSale | −32.3K | $69.84 | −$2.26M | −21.1%120.8K after | 3 lots10b5-1 |
| Aug 26, 2025 (view filing) | Aug 22-26 | 4 days | Jeffs RogerDirector | SSale | −36.7K | $120.05 | −$4.41M | −21.9%131.0K after | 2 lots10b5-1 |
| Aug 29, 2025 (view filing) | Aug 27-29 | 2 days | Jeffs RogerDirector | SSale | −60.0K | $121.72 | −$7.30M | −45.8%71.0K after | 3 lots10b5-1 |
| Sep 2, 2025 (view filing) | Sep 2 | Same day | Jeffs RogerDirector | SSale | −13.5K | $123.68 | −$1.67M | −19.0%57.5K after | 10b5-1 |
| Jun 11, 2026 (view filing) | Jun 10-11 | 1 day | Jeffs RogerDirector | SSale | −572 | $247.65 | −$141.7K | −1.0%58.4K after | 2 lots10b5-1 |